ELMMB logo
Facebook logo Twitter logo
Menu
MHRA Drug Safety Updates

MHRA Drug Safety Updates

MHRA Yellow Card Scheme: please help to reverse the decline in reporting of suspected adverse drug reactions 

Drug Safety Update MHRA June 2019 PDF.pdf

Drug Safety Update MHRA June 2019 PDF.pdf
Summary: Direct-acting oral anticoagulants (DOACs): increased risk of recurrent thrombotic events in patients with antiphospholipid syndrome . GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued . Lartruvo▼ (olaratumab): withdrawal of the EU marketing authorisation due to lack of efficacy . Oral retinoid medicines▼: revised and simplified pregnancy prevention educational materials for healthcare professionals and women
File Size: 274KB
File Type: application/pdf
Created: 20 June 2019
Last Modified: 11 September 2019